Rectibiom Hemorrhoid Relief
NDC Package 72959-005-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Rectibiom Hemorrhoid Relief is a . Marketed by Biom Pharmaceutical Corporation, this product is identified by NDC 72959-005 and is authorized under FDA application part346.

Identification & Billing

NDC Package Code
72959-005-01
Package Description
15 SUPPOSITORY in 1 BOX
Product Code
72959-005
11-Digit Billing Format
72959000501

Clinical Specifications

Proprietary Name
Rectibiom Hemorrhoid Relief
Dosage Form
-

Regulatory & Marketing

Labeler Name
Biom Pharmaceutical Corporation
FDA Application #
part346
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-15-2023
End Marketing Date
03-30-2023
Listing Expiration
03-30-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72959-005-01 identifies a specific commercial package of 15 suppository in 1 box of Rectibiom Hemorrhoid Relief, labeled by Biom Pharmaceutical Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Biom Pharmaceutical Corporation on March 15, 2023. The current certification is valid through March 30, 2023.

How is this Biom Pharmaceutical Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72959000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72959-005-01
11-Digit CMS (5-4-2)
72959-0005-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.